Correlation Between Genenta Science and ESSA Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genenta Science and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genenta Science and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genenta Science SpA and ESSA Pharma, you can compare the effects of market volatilities on Genenta Science and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genenta Science with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genenta Science and ESSA Pharma.

Diversification Opportunities for Genenta Science and ESSA Pharma

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Genenta and ESSA is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Genenta Science SpA and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Genenta Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genenta Science SpA are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Genenta Science i.e., Genenta Science and ESSA Pharma go up and down completely randomly.

Pair Corralation between Genenta Science and ESSA Pharma

Given the investment horizon of 90 days Genenta Science SpA is expected to generate 0.66 times more return on investment than ESSA Pharma. However, Genenta Science SpA is 1.52 times less risky than ESSA Pharma. It trades about 0.1 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.08 per unit of risk. If you would invest  392.00  in Genenta Science SpA on September 2, 2024 and sell it today you would earn a total of  128.00  from holding Genenta Science SpA or generate 32.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genenta Science SpA  vs.  ESSA Pharma

 Performance 
       Timeline  
Genenta Science SpA 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Genenta Science SpA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Genenta Science sustained solid returns over the last few months and may actually be approaching a breakup point.
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Genenta Science and ESSA Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genenta Science and ESSA Pharma

The main advantage of trading using opposite Genenta Science and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genenta Science position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.
The idea behind Genenta Science SpA and ESSA Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets